| | | 50991 | | 15.12.1992 | | Pfizer AG | | 31.05.2007 | | | | | 30.09.2025 | | | | | | 08.01.93. | | | | 08.01.93. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 04 | Tazobac 4,5 g | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Piperacilline 4 g, Tazobactame 0.5 g) | J01CR05 | | | 05 | Tazobac 2,25 g | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Piperacilline 2 g, Tazobactame 0.25 g) | J01CR05 | |
|
|
